{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:31:29Z","timestamp":1790616689061,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016238","name":"Ministry of Economic Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003195","name":"Ministerie van Economische Zaken","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003195","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.metabol.2021.154873","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:10:32Z","timestamp":1630447832000},"page":"154873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk"],"prefix":"10.1016","volume":"124","author":[{"given":"Anita M.","family":"van den Hoek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle C.B.C.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Worms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"van Nieuwkoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Voskuilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin L.","family":"Menke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene","family":"Lek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martien P.M.","family":"Caspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Verschuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154873_bb0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.metabol.2021.154873_bb0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2021.154873_bb0015","doi-asserted-by":"crossref","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovic","year":"2021","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154873_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154873_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154873_bb0030","doi-asserted-by":"crossref","first-page":"G329","DOI":"10.1152\/ajpgi.00044.2018","article-title":"Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis","volume":"315","author":"Hohenester","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2021.154873_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154873_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2021.154873_bb0045","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","article-title":"Lifestyle modification in NAFLD\/NASH: facts and figures","volume":"1","author":"Hallsworth","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.metabol.2021.154873_bb0050","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10620-016-4153-y","article-title":"Lifestyle and dietary interventions in the management of nonalcoholic fatty liver disease","volume":"61","author":"Hannah","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.metabol.2021.154873_bb0055","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s42255-019-0145-5","article-title":"Inter-organ cross-talk in metabolic syndrome","volume":"1","author":"Priest","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2021.154873_bb0060","doi-asserted-by":"crossref","first-page":"154305","DOI":"10.1016\/j.metabol.2020.154305","article-title":"Commentary: from mice to men: in search for dietary interventions to form the background on which pharmacotherapy for non-alcoholic fatty liver disease should be based","volume":"109","author":"Muzurovic","year":"2020","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154873_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010001","article-title":"Diet-independent correlations between bacteria and dysfunction of gut, adipose tissue, and liver: acomprehensive microbiota analysis in feces and mucosa of the ileum and colon in obese mice with NAFLD","volume":"20","author":"Gart","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154873_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081861","article-title":"Sex-specific differences in fat storage, development of non-alcoholic fatty liver disease and brain structure in juvenile HFD-induced obese Ldlr\u2212\/\u2212.Leiden mice","volume":"11","author":"Jacobs","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2021.154873_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201800295","article-title":"Extra-virgin olive oil with natural phenolic content exerts an anti-inflammatory effect in adipose tissue and attenuates the severity of atherosclerotic lesions in Ldlr\u2212\/\u2212.Leiden mice","volume":"62","author":"Luque-Sierra","year":"2018","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.metabol.2021.154873_bb0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphys.2018.00132","article-title":"Key inflammatory processes in human NASH are reflected in Ldlr(\u2212\/\u2212).Leiden mice: a translational gene profiling study","volume":"9","author":"Morrison","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2021.154873_bb0085","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/ijo.2016.74","article-title":"Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR\u2212\/\u2212.Leiden mice","volume":"40","author":"Morrison","year":"2016","journal-title":"Int J Obes (Lond)."},{"key":"10.1016\/j.metabol.2021.154873_bb0090","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep4.1270","article-title":"Obeticholic acid modulates serum metabolites and gene signatures characteristic of human NASH and attenuates inflammation and fibrosis progression in Ldlr\u2212\/\u2212.Leiden mice","volume":"2","author":"Morrison","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.metabol.2021.154873_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/nu9070714","article-title":"Butyrate reduces HFD-induced adipocyte hypertrophy and metabolic risk factors in obese LDLr\u2212\/\u2212.Leiden mice","volume":"9","author":"Pelgrim","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2021.154873_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218459","article-title":"Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr\u2212\/\u2212.Leiden mice","volume":"14","author":"Salic","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154873_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180648","article-title":"A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr\u2212\/\u2212.Leiden mice","volume":"12","author":"Schoemaker","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154873_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092014","article-title":"A translational mouse model for NASH with advanced fibrosis and atherosclerosis expressing key pathways of human pathology","volume":"9","author":"van den Hoek","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.metabol.2021.154873_bb0115","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/ijo.2017.52","article-title":"Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice","volume":"41","author":"Arnoldussen","year":"2017","journal-title":"Int J Obes (Lond)."},{"key":"10.1016\/j.metabol.2021.154873_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184359","article-title":"Combined treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity and liver steatosis","volume":"20","author":"Salic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154873_bb0125","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1096\/fj.202000455R","article-title":"Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr(\u2212\/\u2212).Leiden mice","volume":"34","author":"Tengeler","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2021.154873_bb0130","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1161\/01.ATV.17.11.3064","article-title":"Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes","volume":"17","author":"Post","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154873_bb0135","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154873_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology","volume":"9","author":"Liang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154873_bb0145","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/01.CIR.103.13.1778","article-title":"Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice","volume":"103","author":"Delsing","year":"2001","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154873_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehu319","article-title":"Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin","volume":"36","author":"Kuhnast","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2021.154873_bb0155","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.ATV.15.9.1512","article-title":"A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"15","author":"Stary","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154873_bb0160","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1194\/jlr.D023788","article-title":"Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections","volume":"53","author":"Galarraga","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154873_bb0165","doi-asserted-by":"crossref","DOI":"10.1117\/1.3041159","article-title":"Nonlinear optical microscopy: use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies","volume":"13","author":"Sun","year":"2008","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.metabol.2021.154873_bb0170","first-page":"35","article-title":"A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone","volume":"7","author":"Verschuren","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.metabol.2021.154873_bb0175","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.metabol.2021.154873_bb0180","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-002-0378-7","article-title":"Adiponectin: a link between excess adiposity and associated comorbidities?","volume":"80","author":"Ukkola","year":"2002","journal-title":"J Mol Med (Berl)."},{"key":"10.1016\/j.metabol.2021.154873_bb0185","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.nmd.2004.06.008","article-title":"Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse","volume":"14","author":"Briguet","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.metabol.2021.154873_bb0190","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jgh.12227","article-title":"Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle","volume":"28","author":"Kitajima","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2021.154873_bb0195","doi-asserted-by":"crossref","first-page":"62780","DOI":"10.18632\/oncotarget.19376","article-title":"AMPK: a novel target for treating hepatic fibrosis","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.metabol.2021.154873_bb0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41580-020-0225-0","article-title":"AMPK against NASH","volume":"21","author":"Strzyz","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2021.154873_bb0205","doi-asserted-by":"crossref","first-page":"R1761","DOI":"10.1152\/ajpregu.00422.2009","article-title":"The effects of apelin treatment on skeletal muscle mitochondrial content","volume":"297","author":"Frier","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2021.154873_bb0210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.2012.06738.x","article-title":"Role of PGC-1alpha signaling in skeletal muscle health and disease","volume":"1271","author":"Kang","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2021.154873_bb0215","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/stem.1248","article-title":"CCAAT\/enhancer binding protein beta is expressed in satellite cells and controls myogenesis","volume":"30","author":"Marchildon","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.metabol.2021.154873_bb0220","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1111\/bph.13315","article-title":"Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes","volume":"172","author":"Liang","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2021.154873_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169740","article-title":"The CCR2 inhibitor Propagermanium attenuates diet-induced insulin resistance, adipose tissue inflammation and non-alcoholic steatohepatitis","volume":"12","author":"Mulder","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154873_bb0230","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154873_bb0235","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1126\/science.aay0542","article-title":"An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis","volume":"367","author":"Zhao","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.metabol.2021.154873_bb0240","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2014.09.026","article-title":"TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice","volume":"62","author":"Jiang","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2021.154873_bb0245","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/labinvest.2014.11","article-title":"Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation","volume":"94","author":"Liang","year":"2014","journal-title":"Lab Investig"},{"key":"10.1016\/j.metabol.2021.154873_bb0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.metabol.2021.154873_bb0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/BJ20100285","article-title":"The obese healthy paradox: is inflammation the answer?","volume":"430","author":"Barbarroja","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2021.154873_bb0260","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2021.154873_bb0265","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13578-020-00507-y","article-title":"Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease","volume":"10","author":"Li","year":"2020","journal-title":"Cell Biosci"},{"key":"10.1016\/j.metabol.2021.154873_bb0270","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ijo.2015.226","article-title":"rgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity","volume":"40","author":"Mulder","year":"2016","journal-title":"Int J Obes (Lond)."},{"key":"10.1016\/j.metabol.2021.154873_bb0275","doi-asserted-by":"crossref","first-page":"19353","DOI":"10.1074\/jbc.M201584200","article-title":"Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)\/Lep(ob) mice","volume":"277","author":"Yahagi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154873_bb0280","first-page":"1529","article-title":"Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression","volume":"38","author":"Sekiya","year":"2003","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154873_bb0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/emm.2001.17","article-title":"Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro","volume":"33","author":"Park","year":"2001","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.metabol.2021.154873_bb0290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/jhep.2002.33684","article-title":"Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver","volume":"36","author":"Honda","year":"2002","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154873_bb0295","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00394-015-0841-1","article-title":"A low-fat high-carbohydrate diet reduces plasma total adiponectin concentrations compared to a moderate-fat diet with no impact on biomarkers of systemic inflammation in a randomized controlled feeding study","volume":"55","author":"Song","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.metabol.2021.154873_bb0300","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jamda.2016.04.019","article-title":"Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease","volume":"17","author":"Argiles","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.metabol.2021.154873_bb0305","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.29420","article-title":"Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis","volume":"66","author":"Bhanji","year":"2017","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154873_bb0310","doi-asserted-by":"crossref","unstructured":"Chakravarthy MV, Siddiqui MS, Forsgren MF, Sanyal AJ. Harnessing muscle-liver crosstalk to treat nonalcoholic steatohepatitis. Front Endocrinol (Lausanne). 2020;11:592373.","DOI":"10.3389\/fendo.2020.592373"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:27:28Z","timestamp":1758428848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":62,"alternative-id":["S0026049521001736"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154873","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154873"}}